Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Schedule of Cash Dividends Declared

The following table details our cash dividends declared and paid in 2023 through the date hereof:

					(Dollars in thousands)
Declaration Date	Record Date	Payment Date	Per Share Amount		Total Declared(1)
February 22, 2023	March 16, 2023	March 30, 2023	$	0.3125	$	6,549
Total			$	0.3125	$	6,549

(1) The total declared reflects the cash dividends declared in relation to common stock, deferred stock units ("DSUs") and unvested RSUs.

Schedule of Basic and Diluted Net Loss Per Common Shares

The components of basic and diluted net income (loss) per common share were as follows for the periods stated:

	For the Three Months Ended March 31,
(in thousands, except for share and per share amounts)	2023		2022
Numerator:
Net income (loss)	$	3,117	$	(7,214)
Denominator:
Basic weighted average common shares outstanding	19,897,445		19,599,526
Diluted weighted average common shares outstanding	20,182,692		19,599,526
Basic net income (loss) per common share	$	0.16	$	(0.37)
Diluted net income (loss) per common share	$	0.15	$	(0.37)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the three months ended March 31, 2023, and 2022 the following securities were excluded from the calculation of diluted shares outstanding as the effect would have been anti-dilutive:

	For the Three Months Ended March 31,
	2023	2022
Restricted stock units	—	270,225

Schedule of Activities Under Equity Plan

The following table summarizes the activities under the Equity Plans from January 1, 2023, through March 31, 2023:

	Activity
Total equity securities available at January 1, 2023	683,052
RSU, DSU, and restricted stock awarded to eligible employees, net of forfeitures	(411,935)
Total equity securities available at March 31, 2023	271,117

The following table summarizes the activities under the ESPP from January 1, 2023, through March 31, 2023:

	Activity
Total ESPP equity securities available at January 1, 2023	133,184
ESPP common stock purchased by eligible employees	—
Total ESPP securities available at March 31, 2023	133,184

Summary of Outstanding RSUs

The following table details activities with respect to outstanding RSUs, DSUs, and restricted stock under the Equity Plans for the three months ended March 31, 2023:

	Shares	Weighted Average Grant Date Fair Value
Unvested at January 1, 2023	1,015,749	$	10.25
Granted	441,442	8.19
Vested	(373,103)	11.21
Forfeited	(29,507)	12.08
Unvested at March 31, 2023	1,054,581	$	9.00

Schedule of Stock Based Compensation Expense

The following table reflects the items for stock-based compensation expense in the Condensed Consolidated Statements of Operations for the periods stated:

	For the Three Months Ended March 31,
(Dollars in thousands)	2023		2022
Performance-based RSUs	$	381	$	460
Time-based RSUs, DSUs and restricted stock	542		655
ESPP	13		—
Total stock-based compensation	$	936	$	1,115